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ABSTRACT
IN THE POSTOPERATIVE CARDIOTHORACIC SURGICAL PATIENT
BEING MECHANICALLY VENTILATED, IS THERE A
DIFFERENCE IN OUTCOMES WHEN COMPARING
SEDATION WITH DEXMEDETOMIDINE
VERSUS PROPOFOL?
by Benjamin Heinrich Riebesel
December 2016
Patients undergoing a cardiothoracic operation typically require mechanical
ventilation in the postoperative phase. Each year approximately 395,000 of these
operations are performed in the United States alone. As many as 10% of these patients
require reoperation within the first few hours of recovery due to complications (Barash &
Cullen, 2013). This comprehensive review of the literature was performed to determine
whether postoperative sedation with dexmedetomidine leads to better patient outcomes
than sedation with propofol. Inclusion criteria included publications written in the
English language, articles available in full text, articles written within the last 10 years,
and publications with a focus on a population over the age of 18. Exclusion criteria
included articles not written in the English language, articles not available in full text,
articles not from peer-reviewed journals, and articles focused on pediatric populations. A
comprehensive review of the literature was performed and the results from the included
studies were analyzed regarding patient outcomes in the postoperative cardiothoracic
surgery patient being mechanically ventilated. The results of these studies were compiled
and disseminated via a practice change proposal.
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CHAPTER I - INTRODUCTION
Statement of the Problem
According to the centers for disease control and prevention (CDC) there are
approximately 395,000 cardiothoracic operations performed annually in the United States
(US) alone (Centers for Disease Control and Prevention, 2015). It is estimated that up to
10 % of these patients experience complications following surgery that necessitate them
being brought back to the operating room for additional surgery (Barash & Cullen, 2013).
Examples of complications that can arise are uncontrolled bleeding, graft rupture, aortic
dissection, cardiac tamponade, myocardial infarction, and poor cardiac performance
(Barash & Cullen, 2013).
Patients that have undergone cardiothoracic procedures are brought to the
intensive care unit (ICU) still intubated and placed on mechanical ventilation until they
are deemed stable enough to be extubated. Post-operative mechanical ventilation after
cardiothoracic surgery can be a stressful event for not only the patient but also the nurse
caring for the patient. Sedative agents are commonly used to keep these patients
comfortable until they can be weaned from mechanical ventilation. It is the responsibility
of the healthcare team to ensure that the transition from mechanical ventilation to
extubation goes as smoothly as possible for the patient.
In this new era of modern healthcare, advances have been made to reduce patient
length of stay in the hospital. As a result, many patients are now placed on “fast track”
recovery protocols. The goal of these protocols is to get these patients extubated within
six hours of being in the ICU (Kiessling et al., 2013). Having patients remain on
mechanical ventilation for long periods of time has numerous deleterious effects such as:
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decrease in patient satisfaction, increased cost to the hospital and the patient, and
increased incidence of pneumonia. Since the goal is a rapid recovery, anesthesia
providers have had to change the way these patients are anesthetized for their operations.
Newer sedative medications with shorter duration of actions and fewer side effects are
often being utilized. It is increasingly common for the anesthesia provider to initiate an
intravenous sedative infusion in the operating room and have it continued in to the
postoperative period (Barash & Cullen, 2013).
Clinical Question
Because of the increased postoperative risk that cardiothoracic operations bring
with them, anesthesia providers must carefully tailor all interventions to maximize
positive patient outcomes. A clinical question was prepared to establish if the
administration of dexmedetomidine for postoperative sedation leads to better outcomes
than utilizing propofol for sedation. Does the use of dexmedetomidine lead to better
overall outcomes than with the use of propofol in patients being mechanically ventilated
following cardiothoracic surgery?
Purpose of the Project
The purpose of this capstone project was to assess if overall outcomes improve
due to the use of dexmedetomidine for sedation of mechanically ventilated patients
following cardiothoracic surgery when compared to sedation with propofol. The short
term goal of this project was to influence a clinical practice change and improve patient
outcomes at a level II trauma facility in Mississippi. The long-term goal of this project is
to improve patient outcomes for anyone undergoing a cardiothoracic operation in the
United States.
2

CHAPTER II - METHODOLOGY
A comprehensive review of the literature was conducted using electronic
databases. The following databases were utilized for this review: Nursing OVID,
CINAHL, Google Scholar, and PubMed. Key words that were incorporated into this
systematic review were: cardiac surgery, dexmedetomidine, cardiovascular surgery,
cardiothoracic surgery, postoperative, and sedation. Outcomes from the literature that
were analyzed included: postoperative time spent on mechanical ventilation, incidence of
ventilator associated pneumonia, cost effectiveness of dexmedetomidine, and mortality
and morbidity associated with postoperative sedation. The outcomes listed above were
measured in patients who were receiving either dexmedetomidine or propofol for
postoperative sedation. Findings from the review of these articles will be assembled and
used as the basis of a practice change proposal. This practice change proposal was
presented to a group of Anesthesiologists at a level II trauma hospital in Mississippi. The
intent of this practice change proposal was to attempt to help guide a practice change in
order to help improve patient outcomes for those patients undergoing cardiothoracic
surgery.
Expected Outcomes
The purpose of this DNP project was to assess whether the use of
dexmedetomidine or propofol for sedation of postoperative cardiothoracic surgical
patients led to better outcomes. The anticipated outcome was to improve patient
outcomes as a result of a practice change brought about by the formulation, distribution,
and presentation of a practice change proposal. This practice change proposal was
presented to the Anesthesiologists at a level II trauma hospital in Mississippi with the aid
3

of a formal PowerPoint presentation. After the initial presentation was completed, a short
questionnaire was given to the Anesthesiologists to assess their willingness to adopt a
practice change; the practice change proposal was then made available to the department
with the intent that better patient outcomes would ensue.
Barriers to Implementation
A number of barriers were identified during the course of this DNP project.
There were a limited number of studies performed utilizing dexmedetomidine as a
sedative agent. Uncertainty whether the Anesthesiologists at the local level II trauma
facility would be hesitant to try this newer technique of postoperative sedation was also
present.
Target Population
Articles reviewed for this DNP project included patient populations that were
over the age of 18, had undergone a cardiothoracic surgery, and were on a mechanical
ventilator in the postoperative phase. Cardiothoracic surgery, for the purposes of this
capstone, includes coronary artery bypass grafting, mitral valve replacement, and aortic
valve replacement. Inclusion criteria for articles to be reviewed were: the articles had to
be published within the last 10 years or be seminal articles, and the articles had to be in
the English language. Seminal works are of central importance to a topic; often they are
the first publications written on a specific topic and offer new insight into an area.
Exclusion criteria therefore included articles published more than 10 years ago that were
not seminal articles, and articles published in any language other than English.
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The Importance of Time Spent on Mechanical Ventilation
Reducing the amount of time the patients spend on mechanical ventilation greatly
improves their chance of having a successful, uneventful recovery period. The mainstay
of cardiothoracic surgical patient recovery now is the “fast track” route; this route aims to
have the patient weaned from the mechanical ventilator within six hours (Kiessling et al.,
2013). Patients on mechanical ventilation for a prolonged period of time are at risk for
developing ventilator-associated pneumonia (VAP). Signs and symptoms associated with
VAP include: (a) temperature greater than 38 degrees Celsius, (b) white blood cell count
greater than 12,000, (c) new onset purulent drainage from the endotracheal tube, or
worsening oxygen requirements (Craven & Hjalmarson, 2010). VAP carries with it a
nearly 40% mortality rate and an average cost of $40,000 per occurrence (Craven &
Hjalmarson, 2010).
Lack of Knowledge regarding Dexmedetomidine
Dexmedetomidine is a newer sedative agent that was approved for use by the
Food and Drug Administration (FDA) in 1999. Because it is a relatively new medication,
healthcare providers’ knowledge base regarding the drug may not always be vast.
Dexmedetomidine has a different mechanism of action than most sedative agents and it
does not depress the respiratory center in the brain (Wanat, Fitousis, Boston, & Masud,
2014). Since it does not depress the central respiratory center it does not have to be
discontinued prior to weaning a patient from the mechanical ventilator, this is a major
advantage of this medication over conventional sedative agents. If the patient can be left
adequately sedated while still being arousable to verbal stimuli, which is the key benefit
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to using dexmedetomidine, then tracheal extubation can occur in such a way that it is
comfortable for the patient while still being safe (Karaman et al., 2015).
Clinical Use of Sedative Agents
Sedative agents can help facilitate an uneventful transition from mechanical
ventilation to extubation. Patients can be kept in a quiescent state until vital signs,
hemodynamic values, volume status, and postoperative bleeding are all normalized.
Most institutions use a protocol that contains criteria that help guide the ICU nurse’s
decision to start weaning the patient from mechanical ventilation. Some examples of
criteria that must be met may include the following: fraction of inspired oxygen (Fi02)
less than 50%, hemodynamically stable, awake and alert, able to maintain airway
reflexes, negative inspiratory force of 30 cm water, and a rapid shallow breathing index
(RSBI) of less than 100 (Hensley, Martin, & Gravlee, 2013). The fraction of inspired
oxygen is the concentration of oxygen that is set on the ventilator to be delivered to the
patient; the concentration that is available in the atmosphere is 21%, for the purposes of
weaning ventilatory support a concentration of 50% or less is desirable (Stoelting &
Hillier, 2006). Negative inspiratory force is a test of respiratory muscle strength, during
spontaneous respiration the diaphragm descends causing a negative pressure within the
chest that causes air to rush into the lungs. The negative inspiratory force is simply a way
to quantify how negative the pressure is that the diaphragmatic movement creates, 30 cm
of water pressure is an ideal measurement for this test (Barash & Cullen, 2013). The
rapid shallow breathing index is a ratio that is used to assess whether the patient is taking
breaths that are of adequate depth. The ratio is obtained by dividing the patients breaths
per minute by their tidal volume, so a patient breathing 25 times per minute with a tidal
6

volume of 250cc would have a RSBI of 100 (Barash & Cullen, 2013). After these criteria
have been met the patient can start the process of being weaned from mechanical
ventilation. Depending on the type of sedative agent being used, it may or may not have
to be weaned as well.
Propofol versus Dexmedetomidine
Propofol is an isopropylphenol that is administered intravenously in order to
cause rapid sedation. Propofol exerts its sedative action via activation of the gamma
aminobutyric acid (GABA) receptors. Activation of this receptor causes negatively
charged chloride ions to hyperpolarize the postsynaptic cell membrane of the neuron and
therefore inhibit neuronal excitation (Stoelting & Hillier, 2006). In other words, Propofol
creates an environment within the neuron that makes it more difficult for the cell to send
and receive signals. Propofol is rapidly redistributed to body tissues and the lungs and
then it is metabolized by the oxidative enzyme cytochrome P-450 (Nagelhout & Plaus,
2014). Due to the rapid redistribution of Propofol, patients awaken quickly from a single
bolus dose therefore a continuous infusion is typically utilized. This drug works in a
dose-dependent manner in which a higher dose can be used to provide surgical anesthesia
or a lower dose can be used for sedation in the intensive care unit (ICU). Typical doses
for sedation in the ICU range from 25 to 100 micrograms per kilogram per minute and
can be delivered via a continuous infusion pump (Stoelting & Hillier, 2006). Propofol
produces anesthesia without analgesia and also exhibits a profound respiratory depressant
effect (Nagelhout & Plaus, 2014).
Dexmedetomidine is a sedative agent that works by stimulating the presynaptic
alpha-2 receptor. Presynaptic alpha-2 receptors work as auto regulatory receptors.
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Physiologically, norepinephrine normally binds to this receptor and causes a negative
feedback loop to be initiated. When the receptor is bound, it signals to the presynaptic
neuron that the synapse has an adequate concentration of norepinephrine and no more is
needed. When the drug dexmedetomidine mimics this effect it results in a decreased
level of norepinephrine in the synapse and this in turn leads to sedation (Nagelhout &
Plaus, 2014). In addition to sedation, other physiologic effects can be seen with
administration of dexmedetomidine such as hypotension and bradycardia (Barash &
Cullen, 2013). Dexmedetomidine is metabolized via glucoronidation in the liver and also
by the oxidative enzyme cytochrome P-450. Dexmedetomidine produces sedation at
doses ranging from 0.2 to 1 microgram per kilogram per hour; a loading dose of 1
microgram per kilogram can also be used to rapidly achieve an adequate plasma
concentration. Dexmedetomidine mainly exerts its actions in the locus ceruleus of the
brain stem, therefore it does not depress respiration. One of the main functions of the
locus ceruleus is the maintenance of the sleep-wake cycle. Additionally,
dexmedetomidine exerts some action at the spinal cord level, which is not well
understood, this accounts for its analgesic properties (Nagelhout & Plaus, 2014).
Cost Reduction
Dexmedetomidine use for sedation has been shown to actually decrease that
patient’s hospital bill by an average of $9679 (Wanat et al., 2014). The reason for this
reduction in cost is attributed to a lesser time spent on mechanical ventilation, shortened
hospital stay, and less adjunct medication use such as morphine. The use of
dexmedetomidine has also been shown to decrease incidence of VAP, which can carry
with it a $40,000 cost increase. If the figures provided earlier are extrapolated then there
8

are an estimated 39,500 patients at increased risk of contracting VAP; this could possibly
lead to a cost increase of $1,580,000,000.00 and 15,800 deaths nationwide.
Research Strategy
A comprehensive review of the literature was conducted to determine whether
dexmedetomidine used for sedation of postoperative cardiothoracic surgical patients led
to better patient outcomes than when the drug propofol was used for the same purpose.
Once the systematic review is complete and a conclusion is reached, a practice change
proposal will be made. The intent of this practice change proposal was to influence a
practice change and improve patient outcomes at a level II trauma facility in Mississippi.
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CHAPTER III - COMPREHENSIVE REVIEW OF THE LITERATURE
There is a vast amount of literature that has recently been published supporting
the use of dexmedetomidine for postoperative sedation, specifically for patients that have
undergone cardiothoracic surgery. While reviewing the literature a number of barriers to
the use of dexmedetomidine were identified; they included: (a) concern whether
dexmedetomidine could reduce postoperative ventilation time without increasing adverse
events; (b) concern over total cost-effectiveness of dexmedetomidine vs. propofol; (c)
lack of knowledge regarding advantages and disadvantages of dexmedetomidine for
sedation. This review of the literature will seek to determine whether dexmedetomidine
when used for sedation of postoperative cardiothoracic surgery patients leads to better
patient outcomes than when sedation with propofol is used.
Search Methods
The search of the literature was conducted using the following evidence-based
databases: CINAHL, Nursing OVID, and Pub Med; in addition to the evidence-based
databases already mentioned, Google Scholar was also used as a preliminary search
measure. Search terms that were utilized included cardiac surgery, dexmedetomidine,
cardiovascular surgery, cardiothoracic surgery, postoperative, and sedation. In addition
to the aforementioned search terms, inclusion criteria consisted of articles in the English
language, articles available in full text, articles written within the last 10 years, and
articles that dealt with populations over the age of 18. Exclusion criteria included articles
not written in the English language, articles not available in full text, articles not from
peer-reviewed journals, and articles dealing with pediatric populations. Patient outcomes
that were examined in these articles included time spent on mechanical ventilation,
10

incidence of ventilator associated pneumonia, cost effectiveness of dexmedetomidine,
and mortality and morbidity associated with postoperative mechanical ventilation.
Dexmedetomidine to reduce Postoperative Ventilation Time
The length of time spent on mechanical ventilation in the immediate postoperative
period is crucial. In years past, cardiothoracic surgical patients in the postoperative
period would be sedated and left intubated for up to 24 hours while their fluid status,
hemodynamic parameters, cardiac function, electrolytes, and temperature were being
normalized (Klineberg, Geer, Hirsh, & Aukburg, 1977). Hemodynamic parameters that
are typically monitored in these patients include central venous pressure, pulmonary
artery pressure, pulmonary capillary wedge pressure, blood pressure, stroke volume,
cardiac output, and cardiac index (Barash & Cullen, 2013). It was discovered that
leaving these patients on the ventilator overnight was not exactly leading to the best
patient outcomes. The cardiac surgery community started looking for a better way of
approaching postoperative care for cardiothoracic surgery patients. During the period
from the mid 1970’s to the late 1990’s major advances were made in the intraoperative
and postoperative care of these patients. Some of these advances included the utilization
of transesophageal echocardiography, movement away from use of long acting paralytics
such as pancuronium, and use of a balanced anesthetic technique instead of a primarily
narcotic based approach (Stoelting & Hillier, 2006).
Now the goal in the early postoperative period is to stabilize the patient and wean
them from the ventilator as quickly as possible (Barash & Cullen, 2013). The new trend
in cardiac anesthesia is to “fast-track” cardiothoracic surgical patients. The goal of fasttrack ventilator weaning is to have the patient extubated within six hours (Karaman et al.,
11

2015). Having these patients extubated within six hours reduces the overall incidence of
ventilator-associated pneumonia (VAP). Reducing the incidence of VAP not only
improves patient outcomes but it has also been shown to improve patient satisfaction
scores (Craven & Hjalmarson, 2010). VAP has been shown to be up to 20 times more
common in mechanically ventilated patients. It has been associated with a crude
mortality rate of 20% to 40% and carries with it an average cost of $40,000 per incident
(Craven & Hjalmarson, 2010).
A retrospective observational trial was conducted by Wanut and colleagues
(2014) in which time spent on mechanical ventilation was compared with a group
receiving dexmedetomidine and a group receiving propofol for postoperative sedation.
The patients included in this study had undergone coronary artery bypass grafting
(CABG), mitral valve replacement (MVR), or aortic valve replacement (AVR). Patients
were excluded from the study if they were under the age of 18, were pregnant, had a prior
organ transplant, or were receiving infusions of both dexmedetomidine and propofol.
There was no randomization to the groups, patients received either dexmedetomidine or
propofol for sedation based on the ordering physician preference. The results of the
study showed that patients that received dexmedetomidine (N=33) had a statistically
significant reduction in time spent on the ventilator when compared to patients that
received propofol (N=319), mean ventilation times were 7.4 hours and 12.5 hours
respectively (p value <.042) (Wanat et al., 2014).
Karaman et al. (2015) conducted a randomized controlled trial in patients
undergoing CABG comparing dexmedetomidine to propofol with regard to extubation
time as well as hemodynamic and respiratory parameters, complication rates, and patient
12

satisfaction scores. The study included 70 patients and exclusion criteria included
patients with chronic renal failure, liver failure, congestive heart failure, valvular heart
disease, respiratory system disorders, propofol or dexmedetomidine allergies,
Alzheimer’s disease or dementia, ejection fraction of less than 40%, body mass index of
>30, and a bypass time of >120 minutes. The patients were randomized to receive either
dexmedetomidine or propofol for sedation in the postoperative phase. Dexmedetomidine
was infused at a rate of 0.2-1.0 micrograms per kilogram per hour and propofol was
infused at a rate of 1-3 milligrams per kilogram per hour. The typical infusion rate for
dexmedetomidine is 0.2-0.7 micrograms per kilogram per hour, and the typical infusion
rate for Propofol is 1-3 milligrams per kilogram per hour (Nagelhout & Plaus, 2014).
The study showed that patients that received dexmedetomidine (N=31) had statistically
significant reductions in ventilator time when compared to patients that received propofol
(N=33). Times for the two groups were 266 minutes vs. 323 minutes respectively (p
value <.001) (Karaman et al., 2015). The goal of fast track ventilator weaning in these
patients is 360 minutes (Karaman et al., 2015).
Park et al. (2014) performed a randomized controlled trial on patients undergoing
CABG, aortic valvuloplasty (AVP), mitral valvuloplasty (MVP), and combined CABG
and valve procedures. In this trial dexmedetomidine was compared to remifentanil with
regard to neurological, hemodynamic, and sedative differences. The study included 142
patients that were randomized into either the dexmedetomidine group or the remifentanil
group. Remifentanil is a potent synthetic opioid that is administered via a continuous
infusion; it is broken down in the plasma by red blood cell esterases and as such it has a
half-life of approximately four minutes (Nagelhout & Plaus, 2014). Dexmedetomidine
13

infusion rates were between 0.2-0.8 micrograms per kilogram per hour and remifentanil
infusion rates were between 1-2.5 milligrams per hour. The typical dose of remifentanil
when administered as a continuous infusion is between 0.05-2 milligrams per hour
(Nagelhout & Plaus, 2014). The study failed to demonstrate a reduction in postoperative
ventilation time with dexmedetomidine when compared to remifentanil (p >.05).
However, the study did conclude that the dexmedetomidine group had a statistically
significant reduction in overall incidence of postoperative delirium 8.96% compared to
22.67% (p <.05) (Park et al., 2014). This study also pointed out that it has been shown
that a prolonged amount of time on mechanical ventilation can itself lead to increased
risk of developing delirium by as much as 790% (p <.05) (Park et al., 2014).
Cost Effectiveness
Providing patients with cost effective, safe healthcare is in everyone’s best
interest. There are a number of studies that have been published elucidating the cost
effectiveness of using dexmedetomidine for postoperative sedation. Wanut et al. (2014)
found in their retrospective observational trial that, on average, using dexmedetomidine
for postoperative sedation reduced the hospital bill by $9679.00. This amount of savings
was due to a combination of things such as: decreased length of time on ventilator,
decreased incidence of pneumonia and stress ulcers, decreased length of stay in the
hospital, and less use of adjunct medications such as morphine, beta blockers, and
epinephrine (Wanat et al., 2014).
Ji et al. (2013) conducted a single-center, retrospective cohort study that included
1260 patients that underwent CABG, MVR, or AVR surgery; the aim of their study was
to determine whether perioperative use of dexmedetomidine reduced the incidence of
14

adverse complications and mortality following surgery. Exclusion criteria for this study
included emergency operations, off-pump surgery, robotic surgery, circulatory arrest, and
surgery involving the thoracic aorta. The study showed a decrease in the mortality rate
while in the hospital, 1.23% vs. 4.59% (p < 0.0001). The study also showed a decrease in
the 30 day and 1-year mortality rates, 1.76% vs. 5.12% and 3.17% vs. 7.95% respectively
(p < 0.0001 for both) (Ji et al., 2013). A perioperative infusion of dexmedetomidine was
also shown to decrease the overall incidence of complications (stroke, MI, sepsis, cardiac
arrest, acute renal failure) from 54.06% to 47.18% (p = 0.0136). By decreasing the
likelihood that these patients will experience adverse complications both shortly after
surgery and even up to one year out from surgery, readmission to the hospital in this time
period is decreased. Reimbursement from the Centers for Medicare and Medicaid
Services (CMS) is now tied to readmission rates (Centers for Medicare and Medicaid
Services, 2014), so anything that can be proven to reduce these rates is of great benefit to
an organization and the patient.
Patients are now being given a survey to fill out upon discharge called the
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), the
results of this survey factor into reimbursement for the institution (Centers for Medicare
and Medicaid Services, 2014). Karaman et al. (2015) found that not only did using
dexmedetomidine reduce time spent on mechanical ventilation, it also had a statistically
significant impact of patient satisfaction scores. The average satisfaction score for the
dexmedetomidine group was 9 whereas the mean score for the propofol group was 7
(p value <.001) (Karaman et al., 2015).

15

Knowledge Deficit Regarding Dexmedetomidine
It was found during this review of the literature that there is a generalizable
knowledge deficit regarding the advantages to using dexmedetomidine in the
perioperative setting. The advantages of dexmedetomidine over conventional sedative
agents are numerous. Possibly the most underutilized and unknown benefit of
dexmedetomidine is that the infusion can be continued for up to 24 hours after extubation
(Wanat et al., 2014). Unlike most conventional sedatives that work on the GABA
receptors, dexmedetomidine exerts its action on the presynaptic alpha-2 adrenergic
receptors (Nagelhout & Plaus, 2014). Since its action is mediated through the alpha-2
receptors, which causes sedation by ultimately reducing the amount of norepinephrine in
the synaptic cleft and not by mimicking the body’s own sedative mechanism, the
respiratory center in the brain is not affected. Because of the unique mechanism of action
that dexmedetomidine possesses, it can safely be continued in the period following
tracheal extubation.
Ren et al. (2013) performed a randomized control trial with the aim of evaluating
the impact that dexmedetomidine had on myocardial injury in the postoperative period.
This trial included 162 patients that were undergoing off-pump coronary artery bypass.
Patients were randomized into two groups, one received dexmedetomidine in the
perioperative period while the other received propofol. The study found that using a
dexmedetomidine in the postoperative period led to a decreased serum level of both
norepinephrine and cortisol (p < .05). Norepinephrine and cortisol are both associated
with an increased stress response that is initiated by surgery or trauma. In an already
weakened heart it is important that this stress response be allayed as much as possible.
16

The trial also determined that dexmedetomidine infusions led to a decreased creatinine
kinase MB isoenzyme (CK-MB) levels (p < .05), and a decreased number of myocardial
ischemic events (p < .05) (Ren et al., 2013). Myocardial ischemia ensues when oxygen
demand by the heart outweighs the oxygen supply from the blood (Barash & Cullen,
2013) CK-MB is the isoenzyme of creatinine kinase that is released when myocardial
cells are irreversibly injured (Kumar et al., 2013).
In addition to its sedative effects, dexmedetomidine also offers patients some
analgesic properties. The analgesic properties of dexmedetomidine are due to its alpha-2
adrenergic agonist activity at the level of the spinal cord (Barash & Cullen, 2013). Herr
et al. (2003) conducted a randomized trial spanning 25 hospitals in the United States and
Canada investigating differences in analgesic use, beta blocking agents, antiemetic use,
epinephrine, and diuretics in patients receiving either dexmedetomidine or propofol for
sedation in the ICU after CABG surgery. The study consisted of 295 patients that were
randomized into either the dexmedetomidine group, or the propofol group. It was found
that in the dexmedetomidine group, only 28% of patients required morphine for break
through pain whereas 69% of the patients in the propofol group received morphine (p <
0.001) (Herr et al., 2003). It was also shown that the propofol group received, on
average, four times the amount of morphine that the dexmedetomidine group received
while in the ICU. The dexmedetomidine group also received fewer doses of beta
blockers, antiemetic drugs, epinephrine, and diuretics while in the ICU (Herr et al.,
2003).
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Doctor of Nursing Practice Essentials
Doctor of Nursing Practice (DNP) Essential I is the scientific underpinning for
practice (Zaccagnini & White, 2014). This essential allows the researcher to integrate the
science of nursing along with a nursing theory or concept in order to determine a need
for, and be able to implement a change within a healthcare organization. Nursing
theories are classified according to their philosophy, scope, scale, or perspective
(Zaccagnini & White, 2014). I plan to utilize a middle range theory into this DNP
project. Middle range theories are “specific descriptions, explanations, or predictions
about a phenomenon of interest” which are narrower in scope than grand theories
(Zaccagnini & White, 2014, p. 14). The specific theory that will be incorporated into this
DNP project is the comfort theory by Katherine Kolcaba. The comfort theory has a few
basic assumptions that one must be familiar with in order to apply the theory. The first
basic assumption is that people experience holistic responses to complicated situations.
The second basic assumption is that comfort is indeed a desirable outcome that is
pertinent to nursing. Finally, the third basic assumption is that all people will strive to
have their basic need for comfort met (Kolcaba, 1994). These three assumptions provide
the foundation for the comfort theory and give practitioners a vantage point from which
to view their project. The use of this theory will help to ascertain whether the use of
dexmedetomidine leads to increased comfort when compared to propofol.
DNP Essential II is organizational and systems leadership for quality
improvement and systems thinking (Zaccagnini & White, 2014). This essential assists
the researcher in developing methods to improve healthcare delivery for current and
future patient populations. According to this essential, scientific as well as economic
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findings can be utilized to develop new care delivery approaches. The aim of this project
is to determine whether dexmedetomidine leads to better patient outcomes when
compared to propofol. The main variable that will determine which of these sedative
agents leads to better outcomes is the difference in time to extubation between these two
drugs. Another variable that will be examined in this capstone is the monetary benefit of
utilizing one drug over the other. Both sedative agents provide safe and reliable sedation
of postoperative cardiothoracic surgery patients; however, it is the aim of this capstone to
determine which medication produces better patient outcomes and from there a clinical
practice change will be made with the goal of improving patient safety.
DNP Essential III is clinical leadership and analytical methods for evidence-based
practice (Zaccagnini & White, 2014). This essential helps the researcher to critically
appraise existing literature and determine what is the best evidence for practice. This
capstone project will contain a systematic review of the current literature regarding the
use of dexmedetomidine for the sedation of postoperative cardiothoracic surgery patients.
This review of the literature will be synthesized into a practice change proposal and
presented to a group of local Anesthesiologists in Mississippi with the intent of
influencing a clinical practice change that will improve patient safety.
DNP Essential IV is information systems/technology and patient care technology
for the improvement and transformation of healthcare (Zaccagnini & White, 2014). This
essential is of the utmost importance in today’s healthcare field. Not only is an
understanding of technology and information systems important when performing actual
patient care or performing a retrospective chart review, but it is also essential to be able
to navigate through the electronic databases that contain most of today’s research. To
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perform the systematic review of the literature that will be tantamount to the completion
of this DNP project, multiple electronic sources will need to be navigated in order to find
the relevant material.
DNP Essential V is healthcare policy for advocacy in healthcare (Zaccagnini &
White, 2014). This essential is important for the researcher since it prepares them to
develop policies at the institutional, local, state, and federal levels. It also prepares the
nursing researcher to educated policy makers regarding safety and patient outcomes. A
practice change proposal was written and given to a local anesthesia department with the
hope that it would influence a practice change and improve both patient safety and patient
outcomes.
DNP Essential VI interpersonal collaboration for improving patient and
population health outcomes (Zaccagnini & White, 2014). This essential is vital to the
nursing researcher because the DNP prepared nurse must be able to collaborate with
other professionals in order to establish a meaningful practice change. Interpersonal
relationships must be established by the researcher with this capstone project in order to
influence a change in policy and practice. Also, the presentation of the practice change
proposal relied on interpersonal communication between the researcher and the
Anesthesiologists in order to be effective.
DNP Essential VII is clinical prevention and population health for improving the
nation’s health (Zaccagnini & White, 2014). The DNP prepared nurse must be able to
analyze scientific data related to their population of interest and synthesize that data into
meaningful, easy to use information that can be utilized to help implement and evaluate a
change in practice. Dexmedetomidine used as a postoperative sedative agent for patients
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that have undergone a cardiothoracic operation can help reduce time spent on mechanical
ventilation in this patient population. By reducing the amount of time spent on
mechanical ventilation, the incidence of pneumonia is decreased, the patient satisfaction
levels are increased, cost is decreased to the patient and facility, and there are less
postoperative myocardial ischemic events. So by implementing the latest evidence based
findings with regard to postoperative sedation of cardiothoracic surgery patients, patient
outcomes can be greatly enhanced.
DNP Essential VIII is advanced nursing practice (Zaccagnini & White, 2014). It
is essential to develop and maintain relationships with other healthcare professionals in
order to provide better patient care and improve patient outcomes. Professional
relationships that are made within the anesthesia department at the local level II trauma
hospital will be nurtured in order to obtain a lasting, significant practice change at this
facility. Also, it is imperative to be able to demonstrate a superior ability to be able to
evaluate research to ascertain what the best evidence-based practice is. Within this DNP
project there is a comprehensive review of the literature that contains the latest research
on the issue of utilizing dexmedetomidine for sedation of postoperative cardiothoracic
surgery patients. At the conclusion of the literature review section it is clear what the
best evidence for this particular topic is. With this evidence in hand, a practice change
proposal was written and given to the local anesthesia department for consideration for
implementation.
Practice Change Proposal
According to the centers for disease control and prevention (CDC) there are
approximately 395,000 cardiothoracic operations performed annually in the United States
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alone (Centers for Disease Control and Prevention, 2015). It is estimated that up to 10%
of these patients experience complications following surgery that necessitate them being
brought back to the operating room for additional surgery (Barash & Cullen, 2013).
Examples of complications that can arise are uncontrolled bleeding, graft rupture, aortic
dissection, cardiac tamponade, myocardial infarction, and poor cardiac performance
(Barash & Cullen, 2013).
These patients are brought from the operating room to the intensive care unit and
placed on a mechanical ventilator until they are strong enough to be weaned from
ventilator support. This period is particularly stressful for the patient as they make the
transition from being ventilated to maintain their own airway. The majority of these
patients require some type of sedation until their hemodynamics stabilize to the point that
they can start to be weaned from the ventilator. The typical sedative that is used for
ventilated patients in the ICU is propofol.
Propofol is an isopropylphenol that is administered intravenously in order to
cause rapid sedation. Propofol exerts its sedative action via activation of the gamma
aminobutyric acid receptors. Activation of this receptor causes negatively charged
chloride ions to hyperpolarize the postsynaptic cell membrane of the neuron and therefore
inhibit neuronal excitation (Stoelting & Hillier, 2006). In other words, Propofol creates
an environment within the neuron that makes it more difficult for the cell to send and
receive signals. Propofol is rapidly redistributed to body tissues and the lungs and then it
is metabolized by the oxidative enzyme cytochrome P-450 (Nagelhout & Plaus, 2014).
Due to the rapid redistribution of Propofol, patients awaken quickly from a single bolus
dose therefore a continuous infusion is typically utilized.
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An alternative drug is also available for sedation of these patients,
dexmedetomidine. Dexmedetomidine is a sedative agent that works by stimulating the
presynaptic alpha-2 receptor. Presynaptic alpha-2 receptors work as auto regulatory
receptors. Physiologically, norepinephrine normally binds to this receptor and causes a
negative feedback loop to be initiated. When the receptor is bound, it signals to the
presynaptic neuron that the synapse has an adequate concentration of norepinephrine and
no more is needed. When the drug dexmedetomidine mimics this effect it results in a
decreased level of norepinephrine in the synapse and this in turn leads to sedation
(Nagelhout & Plaus, 2014). In addition to sedation, other physiologic effects can be seen
with administration of dexmedetomidine such as hypotension and bradycardia (Barash &
Cullen, 2013). Dexmedetomidine is metabolized via glucoronidation in the liver and also
by the oxidative enzyme cytochrome P-450. Dexmedetomidine produces sedation at
doses ranging from 0.2 to 1 microgram per kilogram per hour; a loading dose of 1
microgram per kilogram can also be used to rapidly achieve an adequate plasma
concentration. Dexmedetomidine mainly exerts its actions in the locus ceruleus of the
brainstem, therefore it does not depress respiration. One of the main functions of the
locus ceruleus is the maintenance of the sleep-wake cycle. Additionally,
dexmedetomidine exerts some action at the spinal cord level, which is not well
understood, this accounts for its analgesic properties (Nagelhout & Plaus, 2014).
The purpose of this DNP project was to determine whether sedation with
dexmedetomidine leads to better patient outcomes when compared to sedation with
propofol. A comprehensive review of the literature was performed and outcomes were
compared between propofol and dexmedetomidine. The results of the literature review
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were taken to a level II trauma center in Mississippi and discussed with the staff
Anesthesiologists there. The Anesthesiologists were given a short questionnaire
inquiring whether or not they would be willing to change their practice based on the
current literature. Eighty percent (4/5) of the Anesthesiologists that were presented with
this information said that they would consider a practice change, the only one that did not
say yes instead said “maybe”.
Some findings from the review of the literature are as follows. Dexmedetomidine
use was found to lead to a shorter duration of time spent on mechanical ventilation when
compared to propofol (Wanat et al., 2014). Patients who spend less time on the ventilator
are less susceptible to acquiring VAP, which carries with it a 40% crude mortality rate
(Craven & Hjalmarson, 2010). The use of dexmedetomidine was proven to reduce the
overall hospital bill by approximately $9679 (Wanat et al., 2014); this was due to a
number of variables such as decreased time spent on mechanical ventilation, decreased
length of stay in ICU and decrease in adjunct medication given (morphine, epinephrine,
beta blockers). In hospital, 30 day, and 1 year mortality rates were also all proven to be
lower in the dexmedetomidine patients (Ji et al., 2013).
Based on the information gleaned from the review of the literature and compiled
within this DNP project, dexmedetomidine is a superior sedative agent when compared to
propofol for postoperative sedation of cardiothoracic surgery patients. The
recommendation of this capstone project is that dexmedetomidine be used for sedation in
this patient population. Furthermore, is it also recommended that the changes proposed
within this capstone project be tested for accuracy to determine whether a real world
practice change should take place.
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CHAPTER IV – SUMMARY
The goal of this DNP project was to determine whether sedation with
dexmedetomidine leads to better outcomes when compared to sedation with propofol in
the postoperative cardiothoracic surgical patient population. Outcomes in several areas
were focused on when the review of the literature was conducted. These areas included:
postoperative time spent on mechanical ventilation, incidence of VAP, cost effectiveness
of dexmedetomidine, and mortality and morbidity associated with postoperative sedation.
A comprehensive review of the literature was conducted and the results from
these randomized controlled trials and retrospective studies were compiled within this
capstone project. These results were then presented to the staff Anesthesiologists at a
level II trauma hospital in Mississippi with a subsequent survey on whether or not they
would consider a practice change based upon the evidence from the literature.
Summary of Findings
The most influential finding of this systematic review of the literature was that the
use of dexmedetomidine lead to a decreased amount of time spent on mechanical
ventilation. Due to the reduced amount of time spent on the ventilator the patients’ risk
of acquiring VAP were also reduced; VAP carries with it a 40% mortality rate and a cost
of up to $40,000. This literature review also showed that the patients receiving
dexmedetomidine were discharged from the intensive care unit faster and required
significantly less pain medication.
The use of dexmedetomidine for postoperative sedation of cardiothoracic surgical
patients was also shown to decrease mortality rates. The in-hospital mortality rate
decreased from 4.59% to 1.23%, the 30-day and 1-year mortality rates both also
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decreased by a significant amount (5.12% to 1.76% and 7.95% to 3.17% respectively).
Lastly, the cost effectiveness of utilizing dexmedetomidine was analyzed. One study
found that patients receiving dexmedetomidine postoperatively had a reduction in their
hospital bills by an average of $9679. This cost reduction was attributed to less time
spent on mechanical ventilation, less time in the ICU and fewer adjunct medications
administered.
Following the completion of the review of the literature and after IRB approval
was obtained, the results of this literature review were presented to the staff
Anesthesiologists at a local level II trauma facility. Of the 5 Anesthesiologists that were
presented with these results, 4 of them stated that they would consider a practice change
and the other one stated “maybe” when asked about a practice change.
Recommendations
This review of the literature showed that the use of dexmedetomidine for sedation
of postoperative cardiothoracic surgical patients leads to better patient outcomes and
overall decreased cost to the patient. The next step in the process of implementing this
practice change proposal will be to get surgeon approval; without their help this proposal
will not be successful. The recommendation of this DNP project is that someone take
this literature review a step further and present these results to the cardiothoracic
surgeons at the level II trauma hospital in Mississippi. The results of this capstone
project should then be tested to determine if the results are significant enough to warrant
a clinical practice change.
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Conclusion
The aim of this DNP project was to determine whether sedation with
dexmedetomidine lead to better patient outcomes when compared with propofol sedation.
The ultimate desire is to influence a practice change based upon the evidence discovered
in the literature. It is my sincere belief that the results found within this DNP project and
the practice change proposal will help clinicians make better decisions regarding sedation
for their patients and ultimately will improve patient outcomes.
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APPENDIX E – Comfort Theory Framework
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